89 Background: Preservation of EF is a goal of care for many men with newly diagnosed
prostate cancer. In order to accurately counsel patients regarding their likely treatment …

PURPOSE: Erectile dysfunction is a common side effect in men treated for prostate cancer.
Previously published studies document the incidence of erectile dysfunction in men treated …

Patient-reported outcome instruments for erectile function often ask respondents about their
experience over the previous 4 wk. This is problematic for baseline assessment of patients …

Introduction Erectile dysfunction (ED) is a common complication following prostate cancer
treatment. Post-treatment erectile function (EF) preservation is strongly dependent on the …

Purpose The purpose of this study is to assess sexual function among patients with clinically
localized prostate cancer referred for radiotherapy and to prospectively evaluate the effect of …

Prostate cancer (PCa) is the most com-mon solid-organ cancer in American males and the
second most common cause of cancer-related death in men. With the advent of prostate …

BACKGROUND The objectives of this survey were to describe the prevalence of using a
treatment for erectile dysfunction (ED) among men after therapy for localized prostate …

OBJECTIVES: To assess potency rate and patient attitudes regarding erectile dysfunction.
METHODS: A multiple choice, self-administered questionnaire distributed to 750 men …

BACKGROUND Published reports of complication rates, such as erectile dysfunction,
associated with treatments for prostate carcinoma are often used to guide patient decision …

Erectile dysfunction is defined as the inability to achieve and/or maintain an adequate
erection satisfactory for penetration. It is an underdiagnosed problem and often attributed to …